Motor vehicle accidents: How should cirrhotic patients be managed

Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver diseas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2012-06, Vol.18 (21), p.2597-2599
Hauptverfasser: Kawaguchi, Takumi, Taniguchi, Eitaro, Sata, Michio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2599
container_issue 21
container_start_page 2597
container_title World journal of gastroenterology : WJG
container_volume 18
creator Kawaguchi, Takumi
Taniguchi, Eitaro
Sata, Michio
description Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver disease. Although MHE is known as a risk factor for MVAs, the impact of diagnosis and treatment of MHE on MVA-related societal costs is largely unknown. Recently, Bajaj et al demonstrated valuable findings that the diagnosis of MHE by rapid screening using the inhibitory control test (ICT), and subsequent treatment with lactulose could substantially reduce the societal costs by preventing MVAs. Besides the ICT and lactulose, there are various diagnostic tools and therapeutic strategies for MHE. In this commentary, we discussed a current issue of diagnostic tools for MHE, including neuropsychological tests. We also discussed the advantages of the other therapeutic strategies for MHE, such as intake of a regular breakfast and coffee, and supplementation with zinc and branched chain amino acids, on the MVA-related societal costs.
doi_str_mv 10.3748/wjg.v18.i21.2597
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3369995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>42326934</cqvip_id><sourcerecordid>1020187369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-ad6ee92272d3e32c0b7a8fbb0d668b0c7a742725285545e75bd9d316b7425cdb3</originalsourceid><addsrcrecordid>eNpVkM9qGzEQh0VpaBy3957K9pbLOtJotVpdCsU0TcEhl-Qs9M-7CuuVLa0d-ip9lrxTXyEydkxyGpj55jfDh9BXgmeUV83V02M725Fm5oHMgAn-AU0AiCihqfBHNCEY81JQ4OfoIqVHjIFSBp_QOUAtMK75BM1vwxhisXOdN70rlDHeumFM_5__FTfhqUhd2Pa2MD7GLozeFGs1-j1QaFes1KBaZz-js6Xqk_tyrFP0cP3rfn5TLu5-_5n_XJSmAhhLZWvnBAAHSx0FgzVXzVJrbOu60dhwxas8ZNAwVjHHmbbCUlLr3GbGajpFPw65661eOWvyG1H1ch39SsW_Migv308G38k27CSltRCC5YDLY0AMm61Lo1z5ZFzfq8GFbZIEAyYNz3RG8QE1MaQU3fJ0hmC5dy-ze5ndy-xe7t3nlW9v3zstvMrOwPdjZheGduOH9sRUQDNFK_oCFqeOfQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1020187369</pqid></control><display><type>article</type><title>Motor vehicle accidents: How should cirrhotic patients be managed</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Sata, Michio</creator><creatorcontrib>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Sata, Michio</creatorcontrib><description>Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver disease. Although MHE is known as a risk factor for MVAs, the impact of diagnosis and treatment of MHE on MVA-related societal costs is largely unknown. Recently, Bajaj et al demonstrated valuable findings that the diagnosis of MHE by rapid screening using the inhibitory control test (ICT), and subsequent treatment with lactulose could substantially reduce the societal costs by preventing MVAs. Besides the ICT and lactulose, there are various diagnostic tools and therapeutic strategies for MHE. In this commentary, we discussed a current issue of diagnostic tools for MHE, including neuropsychological tests. We also discussed the advantages of the other therapeutic strategies for MHE, such as intake of a regular breakfast and coffee, and supplementation with zinc and branched chain amino acids, on the MVA-related societal costs.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v18.i21.2597</identifier><identifier>PMID: 22690067</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Co., Limited</publisher><subject>Accidents, Traffic - prevention &amp; control ; Algorithms ; Amino Acids, Branched-Chain - therapeutic use ; Coffee ; Cognition ; Cognition Disorders - therapy ; Fibrosis - complications ; Fibrosis - therapy ; Field of Vision ; Hepatic Encephalopathy - complications ; Hepatic Encephalopathy - diagnosis ; Humans ; Lactulose - therapeutic use ; Neuropsychological Tests ; Psychometrics ; Risk Factors ; Treatment Outcome ; Wounds and Injuries - prevention &amp; control ; Zinc - therapeutic use ; 交通事故 ; 机动车 ; 电信增值服务 ; 移动增值业务 ; 管理 ; 肝硬化 ; 认知功能障碍 ; 诊断工具</subject><ispartof>World journal of gastroenterology : WJG, 2012-06, Vol.18 (21), p.2597-2599</ispartof><rights>2012 Baishideng Publishing Group Co., Limited. All rights reserved. 2012</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-ad6ee92272d3e32c0b7a8fbb0d668b0c7a742725285545e75bd9d316b7425cdb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369995/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369995/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22690067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawaguchi, Takumi</creatorcontrib><creatorcontrib>Taniguchi, Eitaro</creatorcontrib><creatorcontrib>Sata, Michio</creatorcontrib><title>Motor vehicle accidents: How should cirrhotic patients be managed</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver disease. Although MHE is known as a risk factor for MVAs, the impact of diagnosis and treatment of MHE on MVA-related societal costs is largely unknown. Recently, Bajaj et al demonstrated valuable findings that the diagnosis of MHE by rapid screening using the inhibitory control test (ICT), and subsequent treatment with lactulose could substantially reduce the societal costs by preventing MVAs. Besides the ICT and lactulose, there are various diagnostic tools and therapeutic strategies for MHE. In this commentary, we discussed a current issue of diagnostic tools for MHE, including neuropsychological tests. We also discussed the advantages of the other therapeutic strategies for MHE, such as intake of a regular breakfast and coffee, and supplementation with zinc and branched chain amino acids, on the MVA-related societal costs.</description><subject>Accidents, Traffic - prevention &amp; control</subject><subject>Algorithms</subject><subject>Amino Acids, Branched-Chain - therapeutic use</subject><subject>Coffee</subject><subject>Cognition</subject><subject>Cognition Disorders - therapy</subject><subject>Fibrosis - complications</subject><subject>Fibrosis - therapy</subject><subject>Field of Vision</subject><subject>Hepatic Encephalopathy - complications</subject><subject>Hepatic Encephalopathy - diagnosis</subject><subject>Humans</subject><subject>Lactulose - therapeutic use</subject><subject>Neuropsychological Tests</subject><subject>Psychometrics</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>Wounds and Injuries - prevention &amp; control</subject><subject>Zinc - therapeutic use</subject><subject>交通事故</subject><subject>机动车</subject><subject>电信增值服务</subject><subject>移动增值业务</subject><subject>管理</subject><subject>肝硬化</subject><subject>认知功能障碍</subject><subject>诊断工具</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM9qGzEQh0VpaBy3957K9pbLOtJotVpdCsU0TcEhl-Qs9M-7CuuVLa0d-ip9lrxTXyEydkxyGpj55jfDh9BXgmeUV83V02M725Fm5oHMgAn-AU0AiCihqfBHNCEY81JQ4OfoIqVHjIFSBp_QOUAtMK75BM1vwxhisXOdN70rlDHeumFM_5__FTfhqUhd2Pa2MD7GLozeFGs1-j1QaFes1KBaZz-js6Xqk_tyrFP0cP3rfn5TLu5-_5n_XJSmAhhLZWvnBAAHSx0FgzVXzVJrbOu60dhwxas8ZNAwVjHHmbbCUlLr3GbGajpFPw65661eOWvyG1H1ch39SsW_Migv308G38k27CSltRCC5YDLY0AMm61Lo1z5ZFzfq8GFbZIEAyYNz3RG8QE1MaQU3fJ0hmC5dy-ze5ndy-xe7t3nlW9v3zstvMrOwPdjZheGduOH9sRUQDNFK_oCFqeOfQ</recordid><startdate>20120607</startdate><enddate>20120607</enddate><creator>Kawaguchi, Takumi</creator><creator>Taniguchi, Eitaro</creator><creator>Sata, Michio</creator><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120607</creationdate><title>Motor vehicle accidents: How should cirrhotic patients be managed</title><author>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Sata, Michio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-ad6ee92272d3e32c0b7a8fbb0d668b0c7a742725285545e75bd9d316b7425cdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Accidents, Traffic - prevention &amp; control</topic><topic>Algorithms</topic><topic>Amino Acids, Branched-Chain - therapeutic use</topic><topic>Coffee</topic><topic>Cognition</topic><topic>Cognition Disorders - therapy</topic><topic>Fibrosis - complications</topic><topic>Fibrosis - therapy</topic><topic>Field of Vision</topic><topic>Hepatic Encephalopathy - complications</topic><topic>Hepatic Encephalopathy - diagnosis</topic><topic>Humans</topic><topic>Lactulose - therapeutic use</topic><topic>Neuropsychological Tests</topic><topic>Psychometrics</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>Wounds and Injuries - prevention &amp; control</topic><topic>Zinc - therapeutic use</topic><topic>交通事故</topic><topic>机动车</topic><topic>电信增值服务</topic><topic>移动增值业务</topic><topic>管理</topic><topic>肝硬化</topic><topic>认知功能障碍</topic><topic>诊断工具</topic><toplevel>online_resources</toplevel><creatorcontrib>Kawaguchi, Takumi</creatorcontrib><creatorcontrib>Taniguchi, Eitaro</creatorcontrib><creatorcontrib>Sata, Michio</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawaguchi, Takumi</au><au>Taniguchi, Eitaro</au><au>Sata, Michio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Motor vehicle accidents: How should cirrhotic patients be managed</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2012-06-07</date><risdate>2012</risdate><volume>18</volume><issue>21</issue><spage>2597</spage><epage>2599</epage><pages>2597-2599</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver disease. Although MHE is known as a risk factor for MVAs, the impact of diagnosis and treatment of MHE on MVA-related societal costs is largely unknown. Recently, Bajaj et al demonstrated valuable findings that the diagnosis of MHE by rapid screening using the inhibitory control test (ICT), and subsequent treatment with lactulose could substantially reduce the societal costs by preventing MVAs. Besides the ICT and lactulose, there are various diagnostic tools and therapeutic strategies for MHE. In this commentary, we discussed a current issue of diagnostic tools for MHE, including neuropsychological tests. We also discussed the advantages of the other therapeutic strategies for MHE, such as intake of a regular breakfast and coffee, and supplementation with zinc and branched chain amino acids, on the MVA-related societal costs.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Co., Limited</pub><pmid>22690067</pmid><doi>10.3748/wjg.v18.i21.2597</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2012-06, Vol.18 (21), p.2597-2599
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3369995
source MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Accidents, Traffic - prevention & control
Algorithms
Amino Acids, Branched-Chain - therapeutic use
Coffee
Cognition
Cognition Disorders - therapy
Fibrosis - complications
Fibrosis - therapy
Field of Vision
Hepatic Encephalopathy - complications
Hepatic Encephalopathy - diagnosis
Humans
Lactulose - therapeutic use
Neuropsychological Tests
Psychometrics
Risk Factors
Treatment Outcome
Wounds and Injuries - prevention & control
Zinc - therapeutic use
交通事故
机动车
电信增值服务
移动增值业务
管理
肝硬化
认知功能障碍
诊断工具
title Motor vehicle accidents: How should cirrhotic patients be managed
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A11%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Motor%20vehicle%20accidents%EF%BC%9A%20How%20should%20cirrhotic%20patients%20be%20managed&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Kawaguchi,%20Takumi&rft.date=2012-06-07&rft.volume=18&rft.issue=21&rft.spage=2597&rft.epage=2599&rft.pages=2597-2599&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v18.i21.2597&rft_dat=%3Cproquest_pubme%3E1020187369%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1020187369&rft_id=info:pmid/22690067&rft_cqvip_id=42326934&rfr_iscdi=true